HPV Prevalence in 16-20 Year Old Males
Evaluation of the Impact of Quebec HPV Immunization Program: Prevalence of HPV Types in 16-20 Year Old Males
1 other identifier
observational
681
1 country
1
Brief Summary
In Quebec, 18 birth cohorts of girls were vaccinated against HPV (aged 9 to 29 years in 2020). With an observed vaccination coverage of \>80% an important herd effect might be expected. This study aim is to measure the HPV types prevalence in unvaccinated sexually active boys aged 16 to 20 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2020
CompletedFirst Submitted
Initial submission to the registry
March 3, 2020
CompletedFirst Posted
Study publicly available on registry
March 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMarch 5, 2020
March 1, 2020
11 months
March 3, 2020
March 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of HPV 6/11/16/18/31/33/45/52 and 58
Unvaccinated sexually active 16-20 year old boys will be tested
Up to 18 months
Secondary Outcomes (1)
Prevalence of 31 HPV types
Up to 18 months
Study Arms (1)
Unvaccinated against HPV boys
Sexually active unvaccinated against HPV 16-20 years old boys.
Interventions
Self collected genital samples to be tested for the presence of different HPV types.
Eligibility Criteria
Sexually active 16-20 years old boys studying at a professional school or college.
You may qualify if:
- unvaccinated against HPV
- sexually active
You may not qualify if:
- received an HPV vaccine
- non sexually active
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
Laval University Research Hospital Center
Québec, G1E7G9, Canada
Related Publications (1)
Wolfe C, Ionescu IG, Mayrand MH, Coutlee F, Sauvageau C. Prevalence of Human Papillomavirus Genotypes in Unvaccinated 16- to 20-Year-Old Men in Quebec, Canada. J Infect Dis. 2025 Aug 14;232(2):e203-e212. doi: 10.1093/infdis/jiaf094.
PMID: 39982898DERIVED
Biospecimen
Self collected genital sample.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2020
First Posted
March 5, 2020
Study Start
February 20, 2020
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
March 5, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with any researcher outside this study